2006
Cost-Effectiveness of Second-Generation Antipsychotics and Perphenazine in a Randomized Trial of Treatment for Chronic Schizophrenia
Rosenheck RA, Leslie DL, Sindelar J, Miller EA, Lin H, Stroup TS, McEvoy J, Davis SM, Keefe RS, Swartz M, Perkins DO, Hsiao JK, Lieberman J. Cost-Effectiveness of Second-Generation Antipsychotics and Perphenazine in a Randomized Trial of Treatment for Chronic Schizophrenia. American Journal Of Psychiatry 2006, 163: 2080-2089. PMID: 17151158, DOI: 10.1176/ajp.2006.163.12.2080.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAntipsychotic AgentsChronic DiseaseCost-Benefit AnalysisDrug CostsFollow-Up StudiesHealth Care CostsHumansLongitudinal StudiesMiddle AgedPatient DropoutsPerphenazinePsychiatric Status Rating ScalesQuality-Adjusted Life YearsResearch DesignSchizophreniaSchizophrenic PsychologyTreatment Outcome
1997
Impact of representative payees on substance use by homeless persons with serious mental illness
Rosenheck R, Lam J, Randolph F. Impact of representative payees on substance use by homeless persons with serious mental illness. Psychiatric Services 1997, 48: 800-806. PMID: 9175189, DOI: 10.1176/ps.48.6.800.Peer-Reviewed Original ResearchMeSH KeywordsAdultAlcoholismCase ManagementDiagnosis, Dual (Psychiatry)Eligibility DeterminationFemaleHumansIll-Housed PersonsIllicit DrugsLegal GuardiansMaleMental DisordersMiddle AgedMotivationPatient Care TeamPatient DropoutsPsychotropic DrugsPublic AssistanceSocial SecuritySubstance Abuse DetectionSubstance-Related DisordersTreatment OutcomeUnited StatesConceptsSerious mental illnessSubstance use disordersMental illnessSubstance useUse disordersAdditional clinical benefitFactorial repeated-measures analysisSevere mental illnessHomeless personsCase management servicesStructured behavioral interventionsSubstance abuse outcomesRepresentative payeeRepeated-measures analysisClinical benefitPublic support paymentsAbused substancesDual diagnosisCommunity careSubstance abuseBehavioral interventionsIllnessAbuse outcomesClient subgroupsGreater improvement
1995
Effect of clinician-veteran racial pairing in the treatment of posttraumatic stress disorder
Rosenheck R, Fontana A, Cottrol C. Effect of clinician-veteran racial pairing in the treatment of posttraumatic stress disorder. American Journal Of Psychiatry 1995, 152: 555-563. PMID: 7694904, DOI: 10.1176/ajp.152.4.555.Peer-Reviewed Original ResearchMeSH KeywordsAdultAmbulatory CareAntidepressive AgentsBlack or African AmericanCommunity Mental Health ServicesHumansMaleMiddle AgedPatient Acceptance of Health CarePatient DropoutsProgram EvaluationPsychotherapyPsychotropic DrugsStress Disorders, Post-TraumaticTreatment OutcomeUnited StatesUnited States Department of Veterans AffairsVeteransWhite PeopleConceptsPosttraumatic stress disorderImprovement ratingBlack veteransWhite cliniciansWhite veteransStress disorderBlack male veteransWar-related posttraumatic stress disorderClinician raceOutcome of treatmentLow program participationVeterans' raceAntidepressant medicationPrimary clinicianClinical statusClinician characteristicsMale veteransMultivariate analysisSociodemographic characteristicsLess improvementTreatment emphasisVeterans AffairsClinician ratingsSubstance abuseMore treatments